These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31563293)

  • 1. A prospective, single-arm, multicentre clinical evaluation of a new localisation technique using non-radioactive Magseeds for surgery of clinically occult breast lesions.
    Thekkinkattil D; Kaushik M; Hoosein MM; Al-Attar M; Pilgrim S; Gvaramadze A; Hyklova L; Jibril A
    Clin Radiol; 2019 Dec; 74(12):974.e7-974.e11. PubMed ID: 31563293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.
    Zacharioudakis K; Down S; Bholah Z; Lee S; Khan T; Maxwell AJ; Howe M; Harvey J
    Eur J Surg Oncol; 2019 Nov; 45(11):2016-2021. PubMed ID: 31288944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre evaluation of magnetic technology for localisation of non-palpable breast lesions and targeted axillary nodes.
    McCamley C; Ruyssers N; To H; Tsao S; Keane H; Poliness C; Mehta K; Rose A; Baker C; Mann GB
    ANZ J Surg; 2021 Nov; 91(11):2411-2417. PubMed ID: 34405514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving Role of Magseed in Wireless Localization of Breast Lesions: Systematic Review and Pooled Analysis of 1,559 Procedures.
    Gera R; Tayeh S; Al-Reefy S; Mokbel K
    Anticancer Res; 2020 Apr; 40(4):1809-1815. PubMed ID: 32234869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.
    Micha AE; Sinnett V; Downey K; Allen S; Bishop B; Hector LR; Patrick EP; Edmonds R; Barry PA; Krupa KDC; Rusby JE
    Breast Cancer; 2021 Jan; 28(1):196-205. PubMed ID: 32974810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wireless localisation of breast lesions with MagSeed. A radiological perspective of 300 cases.
    Constantinidis F; Sakellariou S; Chang SL; Linder S; MacPherson B; Seth S; Gill N; Seth A
    Br J Radiol; 2022 May; 95(1133):20211241. PubMed ID: 35201906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magseed localisation of non-palpable breast lesions: experience from a single centre.
    Ross FA; Elgammal S; Reid J; Henderson S; Kelly J; Flinn R; Miller G; Sarafilovic H; Tovey SM
    Clin Radiol; 2022 Apr; 77(4):291-298. PubMed ID: 35177228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study.
    Harvey JR; Lim Y; Murphy J; Howe M; Morris J; Goyal A; Maxwell AJ
    Breast Cancer Res Treat; 2018 Jun; 169(3):531-536. PubMed ID: 29453521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial.
    Žatecký J; Kubala O; Coufal O; Kepičová M; Faridová A; Rauš K; Lerch M; Peteja M; Brát R
    Breast Care (Basel); 2021 Aug; 16(4):383-388. PubMed ID: 34602944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation study.
    Morgan JL; Bromley HL; Dave RV; Masannat Y; Masudi T; Mylvaganam S; Elgammal S; Barnes N; Down S; Holcombe C; Potter S; Gardiner MD; Maxwell AJ; Somasundaram SK; Sami A; Kirwan C; Harvey J;
    Eur J Surg Oncol; 2022 Dec; 48(12):2408-2413. PubMed ID: 36068125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions-The North Wales experience.
    Powell M; Gate T; Kalake O; Ranjith C; Pennick MO
    Breast J; 2021 Jun; 27(6):529-536. PubMed ID: 33855763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of the Magseed
    Crèvecoeur J; Jossa V; Di Bella J; Coibion M; Crèvecoeur A
    Gland Surg; 2023 May; 12(5):566-576. PubMed ID: 37284712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Accuracy of Using Magnetic Seed for Preoperative Non-Palpable Breast Lesions Localization: Our Experience with Magseed.
    D'Angelo A; Trombadori CML; Caprini F; Lo Cicero S; Longo V; Ferrara F; Palma S; Conti M; Franco A; Scardina L; D'Archi S; Belli P; Manfredi R
    Curr Oncol; 2022 Nov; 29(11):8468-8474. PubMed ID: 36354727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial.
    Singh P; Scoggins ME; Sahin AA; Hwang RF; Kuerer HM; Caudle AS; Mittendorf EA; Thompson AM; Bedrosian I; Teshome M; DeSnyder SM; Meric-Bernstam F; Hunt KK
    Ann Surg Open; 2020 Dec; 1(2):e008. PubMed ID: 34017965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magseed placement before neoadjuvant chemotherapy to facilitate subsequent breastconserving surgery - a single-centre audit.
    Malherbe F; Roodt L; Noor F; Gamieldien R; Chetty D; Anderson D; Thebe T; Cairncross L
    S Afr J Surg; 2022 Jun; 60(2):109-114. PubMed ID: 35851364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.
    Postma EL; Verkooijen HM; van Esser S; Hobbelink MG; van der Schelling GP; Koelemij R; Witkamp AJ; Contant C; van Diest PJ; Willems SM; Borel Rinkes IH; van den Bosch MA; Mali WP; van Hillegersberg R;
    Breast Cancer Res Treat; 2012 Nov; 136(2):469-78. PubMed ID: 23053639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.
    Greenwood HI; Wong JM; Mukhtar RA; Alvarado MD; Price ER
    AJR Am J Roentgenol; 2019 Oct; 213(4):953-957. PubMed ID: 31166765
    [No Abstract]   [Full Text] [Related]  

  • 18. Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study.
    Bravo EI; Martínez AM; Alvà HP; Sancho DR; López JCA; Sánchez JA; Casa PE; de Las Heras CG; Venegas MAF; Vidal EG; Begines ED; Mur CG; Vicente I; Casamayor C; Cruz S; Barrado AG
    Breast Cancer Res Treat; 2024 Nov; 208(1):133-143. PubMed ID: 38898360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience of magnetic seed localization for impalpable breast lesion excision: First 100 cases performed in a single Irish tertiary referral centre.
    Murphy E; Quinn E; Stokes M; Kell M; Barry M; Flanagan F; Walsh SM
    Surgeon; 2022 Jun; 20(3):e36-e42. PubMed ID: 33840595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radio-frequency identification (RFID) tag localisation of non-palpable breast lesions a single centre experience.
    Almalki H; Rankin AC; Juette A; Youssef MG
    Breast; 2023 Jun; 69():417-421. PubMed ID: 37141675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.